tocophersolan has been researched along with Hepatocellular Carcinoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 8 (47.06) | 2.80 |
| Authors | Studies |
|---|---|
| Gui, S; Guo, J; He, N; Huang, Y; Li, Z; Liang, X; Tang, M; Tao, Y | 1 |
| Attia, Y; El-Nabarawi, M; Mahmoud, K; Swidan, S; Teaima, M | 1 |
| Li, X; Li, Z; Lian, D; Liu, J; Ye, L | 1 |
| Chen, H; Li, W; Lu, Y; Tao, R; Wang, C; Zhang, C; Zhou, H | 1 |
| Kurmi, BD; Paliwal, R; Paliwal, SR; Tekchandani, P | 1 |
| Li, D; Liu, S; Shen, L; Zhang, QY; Zhu, H; Zhu, J | 1 |
| Du, Z; Fu, J; Hu, J; Mao, Y; Yin, J; You, Q; Zhang, P | 1 |
| Huang, QF; Jiang, YY; Liu, M; Lu, XX; Shao, CL; Wang, GH; Zhang, JM | 1 |
| Bian, J; Cai, J; Luo, S; Tsend-Ayush, A; Wen, J; Yao, J; Yin, L; Yuan, Z; Zhou, J; Zhu, X | 1 |
| Chen, D; Gao, J; Lu, Y; Pan, X; Xie, F; Yin, C; Zhang, Y; Zou, H | 1 |
| Li, A; Liang, Y; Lyu, Y; Tang, X; Xie, D; Zheng, D | 1 |
| Chu, M; Guo, Y; Liu, H; Otieno, BO; Tan, S; Xu, C; Yang, X; Zhang, Z; Zhao, S | 1 |
| Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH | 1 |
| Guo, Y; Si, L; Song, Q; Tan, S; Wu, T; Ye, Q; Zhang, Z; Zhao, Y; Zhuang, X | 1 |
| Chen, M; Fang, X; Li, Y; Wang, Y; Zhang, J; Zhou, D | 1 |
| Liu, G; Mei, L; Tao, W; Wang, T; Zeng, X; Zhang, H; Zhang, L; Zhu, D | 1 |
| Lu, Y; Shan, W; Wang, T; Xiong, S; Yin, X | 1 |
17 other study(ies) available for tocophersolan and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Sorafenib-Loaded PLGA-TPGS Nanosystems Enhance Hepatocellular Carcinoma Therapy Through Reversing P-Glycoprotein-Mediated Multidrug Resistance.
Topics: alpha-Tocopherol; Animals; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Glycolates; Humans; Lactic Acid; Liver Neoplasms; Mice; Mice, Nude; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sorafenib; Vitamin E | 2022 |
Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling.
Topics: alpha-Tocopherol; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Lipids; Liver Neoplasms; Nanocapsules; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Simvastatin; Tissue Distribution | 2023 |
Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Dendrimers; Drug Delivery Systems; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Nanoparticles; Polymers; Sorafenib; Vitamin E; Xenograft Model Antitumor Assays | 2020 |
Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
Topics: Antineoplastic Agents; Betulinic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Delivery Systems; Drug Liberation; Fullerenes; Humans; Lipids; Liver Neoplasms; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Pentacyclic Triterpenes; Polyprenols; Triterpenes; Vitamin E | 2020 |
Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Drug Development; Female; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Male; Random Allocation; Rats; Tissue Distribution; Vitamin E | 2020 |
Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Benzophenanthridines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Folic Acid; Humans; Liver Neoplasms; Micelles; Nanoparticles; Vitamin E | 2021 |
TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Drug Therapy; Galactose; Humans; Indoles; Infrared Rays; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nitric Oxide Donors; Nitroso Compounds; Photothermal Therapy; Polymers; Rats, Sprague-Dawley; Vitamin E; Xenograft Model Antitumor Assays | 2021 |
Brefeldin A delivery nanomicelles in hepatocellular carcinoma therapy: Characterization, cytotoxic evaluation in vitro, and antitumor efficiency in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brefeldin A; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Female; Humans; Liver Neoplasms; Mice, Inbred BALB C; Micelles; Nanostructures; Polyethylenes; Polypropylenes; Rats, Sprague-Dawley; Tissue Distribution; Vitamin E | 2021 |
Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy.
Topics: Carcinoma, Hepatocellular; Drug Carriers; Etoposide; Glycyrrhetinic Acid; Humans; Micelles; Vitamin E | 2017 |
Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
Topics: Acridines; Animals; Carcinoma, Hepatocellular; Cell Death; Doxorubicin; Drug Delivery Systems; Drug Synergism; Endocytosis; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polyesters; Polyethylene Glycols; Rats, Sprague-Dawley; Stem Cell Transplantation; Stem Cells; Subcutaneous Tissue; Tetrahydroisoquinolines; Tissue Distribution; Tumor Stem Cell Assay; Vitamin E | 2018 |
Therapeutic Effect of Sorafenib-Loaded TPGS-
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Sorafenib; Vitamin E | 2018 |
Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Polymers; Tissue Distribution; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2014 |
A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Oleanolic Acid; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Thiazoles; Vitamin E | 2015 |
Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Doxorubicin; Drug Carriers; Female; Half-Life; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Micelles; Nitric Oxide; Polyethylene Glycols; Rats, Sprague-Dawley; Sarcoma 180; Tissue Distribution; Vitamin E | 2014 |
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Male; Micelles; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Serum Albumin, Bovine; Vitamin E | 2014 |
Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Topics: Animals; Carcinoma, Hepatocellular; Docetaxel; Drug Delivery Systems; Hep G2 Cells; Humans; Indoles; Lactic Acid; Liver Neoplasms, Experimental; Mice; Mice, Nude; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Taxoids; Vitamin E; Xenograft Model Antitumor Assays | 2016 |
Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Emodin; Female; Humans; Leukemia L1210; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred ICR; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Random Allocation; Tissue Distribution; Transferrin; Vitamin E | 2012 |